Oramed Pharmaceuticals Inc. announced the appointment of Yadin Rozov to its Board of Directors effective April 1, 2022. The Board determined that Mr. Rozov qualifies as an independent director under the listing rules of the Nasdaq Capital Market. Mr. Rozov is an investment professional with over twenty years of experience in capital markets, corporate finance, investment banking, and investment management with substantial experience in corporate strategy and governance.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.57 USD | 0.00% | +17.19% | +12.12% |
Jun. 26 | Oramed Pharmaceuticals Board Approves $20 Million Share-Buyback Program | MT |
Jun. 26 | Oramed Pharmaceuticals Inc. announces an Equity Buyback for $20 million worth of its shares. | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.12% | 104M | |
+20.10% | 46.93B | |
+37.77% | 39.08B | |
-8.55% | 38.48B | |
+29.47% | 31.01B | |
-12.26% | 26.14B | |
+11.77% | 25.88B | |
+34.90% | 12.53B | |
-6.83% | 11.36B | |
-12.82% | 10.65B |
- Stock Market
- Equities
- ORMP Stock
- News Oramed Pharmaceuticals Inc.
- Oramed Pharmaceuticals Inc Announces Appoints Yadin Rozov to Its Board of Directors